Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Cetuximab and docetaxal for squamous cell cancer of the head and neck, from ASCO 2008

2009 ASCO Annual Meeting

29 May - 2 Jun 2009

Published: 27 Nov 2008

Views: 16324

Rating:

Save

Professor Jan B. Vermorken

Categories:
Head & neck

Related Videos

Head and Neck Cancers

Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai

Head and Neck Cancers ( Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai )

OncoAlert Round Up for September 8-14, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 8-14, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine...

Dr Lin-Quan Tang - Sun Yat-sen University, Guangzhou, China

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine improves PFS in N2-3 nasopharyngeal carcinoma ( Dr Lin-Quan Tang - Sun Yat-sen University, Guangzhou, China )

2L triple metronomic chemo shows more efficacy in comparison to systemic...

Dr Rushabh Kiran Kothari (PI, CRSF group) - Narayana Multispeciality Hospital...

2L triple metronomic chemo shows more efficacy in comparison to systemic therapy for head and neck cancer ( Dr Rushabh Kiran Kothari (PI, CRSF group) - Narayana Multispeciality Hospital, Ahmedabad, India )

ASCO 2023: Head and neck highlights

Dr Glenn Hanna - Dana-Farber Cancer Institute, Boston, USA

ASCO 2023: Head and neck highlights ( Dr Glenn Hanna - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer